Ignite Creation Date:
2024-05-06 @ 2:06 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04219319
Status:
TERMINATED
Last Update Posted:
2022-08-16
First Post:
2019-11-20
Brief Title:
LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4 T-cell Lymphoma
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Organization Data
Organization:
The First Affiliated Hospital with Nanjing Medical University
Class:
OTHER
Study ID:
BM2L201905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
WEI XU
Responsible Party Title:
Chief Physician of hematology department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital with Nanjing Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nanjing Legend Biotechnology Co The First Affiliated Hospital of USTC west districtThe First Affiliated Hospital of the Air Force Medical University | UNKNOWN |